Yukyeong Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yukyeong Lee has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Kinarm Ko
Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Korea
3 shared publications - Camilla Boschian
Massachusetts General Hospital
1 shared publication Dahee Jeong
Department of Stem Cell Biology Konkuk University School of Medicine Seoul Republic of Korea
1 shared publication- Dahee Jeong
Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul 05029, the Republic of Korea; Center for Stem Cell Research, Institute of Advanced Biomedical Science, Konkuk University, Seoul 05029, the Republic of Korea
1 shared publication - Guangming Wu
Guangzhou National Laboratory, Guangzhou, China
1 shared publication - Hans Robert Schöler
Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Röntgenstrasse 20, 48149 Münster, Germany
1 shared publication
Latest Publications
- Open Access
- 15 September 2025
- Published by Taylor & Francis in RNA Biology
- Vol. 22 (1) , 1-17
MicroRNA-mediated regulation of proliferation, lineage differentiation, and apoptosis in neural stem cells
Neural stem cells (NSCs) are multipotent stem cells with self-renewal capacity, able to differentiate into all neural lineages of the central nervous system, including neurons, oligodendrocytes, and astrocytes; thus, their proliferation and differentiation are essential for embryonic neurodevelopment and adult brain homoeostasis. Dysregulation in these processes is implicated in neurological disorders, highlighting the need to elucidate how NSCs proliferate and differentiate to clarify the mechanisms of neurogenesis and uncover potential therapeutic targets. MicroRNAs (miRNAs) are small, post-transcriptional regulators of gene expression involved in many aspects of nervous system development and function. Multiple studies have shown that miRNAs control the balance between self-renewal and differentiation during development through transcriptional networks and fine-tuned signalling pathways. They also regulate key biological processes, including cell fate determination, developmental timing, neurogenesis, gliogenesis, and apoptosis. Transcriptomic analyses and high-resolution profiling have revealed temporally and spatially restricted miRNA expression patterns in NSCs and their progeny, suggesting highly context-dependent regulatory functions. Here, we provide an integrated overview of recent advances in miRNA biology relevant to NSC maintenance and lineage specification, with a focus on the mechanistic understanding of miRNA roles in neuronal differentiation, glial development, and programmed cell death across neural development.
- 15 September 2025
- Published by Taylor & Francis in RNA Biology
- Vol. 22 (1) , 1-17
Open AccessMicroRNA-mediated regulation of proliferation, lineage differentiation, and apoptosis in neural stem cells
Neural stem cells (NSCs) are multipotent stem cells with self-renewal capacity, able to differentiate into all neural lineages of the central nervous system, including neurons, oligodendrocytes, and astrocytes; thus, their proliferation and differentiation are essential for embryonic neurodevelopment and adult brain homoeostasis. Dysregulation in these processes is implicated in neurological disorders, highlighting the need to elucidate how NSCs proliferate and differentiate to clarify the mechanisms of neurogenesis and uncover potential therapeutic targets. MicroRNAs (miRNAs) are small, post-transcriptional regulators of gene expression involved in many aspects of nervous system development and function. Multiple studies have shown that miRNAs control the balance between self-renewal and differentiation during development through transcriptional networks and fine-tuned signalling pathways. They also regulate key biological processes, including cell fate determination, developmental timing, neurogenesis, gliogenesis, and apoptosis. Transcriptomic analyses and high-resolution profiling have revealed temporally and spatially restricted miRNA expression patterns in NSCs and their progeny, suggesting highly context-dependent regulatory functions. Here, we provide an integrated overview of recent advances in miRNA biology relevant to NSC maintenance and lineage specification, with a focus on the mechanistic understanding of miRNA roles in neuronal differentiation, glial development, and programmed cell death across neural development.
- Open Access
- 5 April 2023
- Published by Elsevier in Molecules and Cells
- Vol. 46 (4) , 209-218
Homogeneity of XEN Cells Is Critical for Generation of Chemically Induced Pluripotent Stem Cells
Dahee Jeong, Yukyeong Lee, Seung-Won Lee, Seokbeom Ham, Minseong Lee, Na Young Choi, Guangming Wu, Hans R. Scholer, and Kinarm Ko. Mol. Cells 2023;46:209-18. https://doi.org/10.14348/molcells.2023.2127
- 5 April 2023
- Published by Elsevier in Molecules and Cells
- Vol. 46 (4) , 209-218
Open AccessHomogeneity of XEN Cells Is Critical for Generation of Chemically Induced Pluripotent Stem Cells
Dahee Jeong, Yukyeong Lee, Seung-Won Lee, Seokbeom Ham, Minseong Lee, Na Young Choi, Guangming Wu, Hans R. Scholer, and Kinarm Ko. Mol. Cells 2023;46:209-18. https://doi.org/10.14348/molcells.2023.2127
- Open Access
- 25 October 2021
- Published by Wiley in Cell Biology International
- Vol. 46 (1) , 139-147
Plant‐derived human recombinant growth factors and serum albumin maintain stemness of human‐induced pluripotent stem cells
Stem cells are an important therapeutic source for recovery and regeneration, as their ability of self‐renewal and differentiation offers an unlimited supply of highly specialized cells for therapeutic transplantation. Growth factors and serum are essential for maintaining the characteristics of stem cells in culture and for inducing differentiation. Because growth factors are produced mainly in bacterial (Escherichia coli) or animal cells, the use of such growth factors raises safety concerns that need to be resolved for the commercialization of stem cell therapeutics. To overcome this problem, studies on proteins produced in plants have been conducted. Here, we describe the functions of plant‐derived fibroblast growth factor 2 (FGF2) and human serum albumin in the maintenance and differentiation of human‐induced pluripotent stem cells (hiPSCs). Plant‐derived FGF2 and human epidermal growth factor EGF were able to differentiate hiPSCs into neural stem cells (NSCs). These NSCs could differentiate into neuronal and glial cells. Our results imply that culturing stem cells in animal‐free culture medium, which is composed of plant‐derived proteins, would facilitate stem cell application research, for example, for cell therapy, by reducing contamination risk.
- 25 October 2021
- Published by Wiley in Cell Biology International
- Vol. 46 (1) , 139-147
Open AccessPlant‐derived human recombinant growth factors and serum albumin maintain stemness of human‐induced pluripotent stem cells
Stem cells are an important therapeutic source for recovery and regeneration, as their ability of self‐renewal and differentiation offers an unlimited supply of highly specialized cells for therapeutic transplantation. Growth factors and serum are essential for maintaining the characteristics of stem cells in culture and for inducing differentiation. Because growth factors are produced mainly in bacterial (Escherichia coli) or animal cells, the use of such growth factors raises safety concerns that need to be resolved for the commercialization of stem cell therapeutics. To overcome this problem, studies on proteins produced in plants have been conducted. Here, we describe the functions of plant‐derived fibroblast growth factor 2 (FGF2) and human serum albumin in the maintenance and differentiation of human‐induced pluripotent stem cells (hiPSCs). Plant‐derived FGF2 and human epidermal growth factor EGF were able to differentiate hiPSCs into neural stem cells (NSCs). These NSCs could differentiate into neuronal and glial cells. Our results imply that culturing stem cells in animal‐free culture medium, which is composed of plant‐derived proteins, would facilitate stem cell application research, for example, for cell therapy, by reducing contamination risk.